A successful entrepreneur and accomplished executive within the international clinical research industry. Strong track record of skillful management through the convergence of expertise in business strategy, operational excellence, technology innovation, and financial acumen. Leadership abilities that have developed world class organizations, driving business transformation to increase profit margins and propel corporate growth.
In a career spanning nearly 30 years, I have started a company in my basement with a business partner and drove that venture into an international business with hundreds of employees and offices across the globe, ultimately selling at a value of nearly 60M. During my tenure as COO of a non-profit research organization in NYC, I oversaw a 20% increase in revenue that was nearly double the headcount growth rate, resulting in margins that enabled the necessary multi-million-dollar office relocation and further funded the important mission of the foundation.
While serving as COO of Bioclinica (owned by PE firm Cinven), I lead an international team of 600+ employees across 10 offices spanning the U.S., Europe, India, China and Japan. In this role, I restructured global operations, achieved or exceeded all budget targets, produced increased margins, identified and lead the acquisition of a novel technology company, and achieved gains in all key metrics for quality, productivity and efficiency.
During my non-compete period after leaving Bioclinica, I served on the executive management team of Abzena (owned by PE firm WCAS), the leading biologics target to GMP Partner Research Organization. I was fortunate to partner with Abzena at a time of unprecedented growth, leading their efforts to empower global operations through the identification, selection, and implementation of enterprise technology solutions.